Chinese companies and Covid-19 vaccines
DOI:
https://doi.org/10.53897/RevChinaGR.2023.01.06Keywords:
pandemia, desarrollo de vacunas, tecnologías de las vacunas, cooperación sanitaria, mercado de vacunasAbstract
The text presents an analysis of China's participation in the development and commercialization of Covid-19 vaccines. The first part explores the development of vaccines and, given the interest in analyzing China's role in the vaccine market, the United States is the geographical reference for comparative purposes, without going any further. The second part studies the cooperative relations between actors (national and foreign) involved in the development of vaccines, in China and the United States; We highlight two phases of vaccine development and use, to show China's retreat and America's progress. In the third part, we highlight the geographical distribution patterns corresponding to the seven main vaccine manufacturing companies, paying particular attention to Sinovac and Beijing CNBG, to show that their main regional markets are in Asia.
Downloads
Metrics
References
AVAC. (2021). Vaccine development history. https://www.avac.org/infographic/vaccine-development-history
COVID-19 Vaccine Tracker. (2022). By the numbers. https://covid19.trackvaccines.org/
COVID-19 Vaccine Tracker. (2022a). Codagenix Inc: COVI-VAC. https://covid19.trackvaccines.org/vaccines/59/
Corum, J. y Zimmer, K. (2021a, 4 de agosto). Cómo funciona la vacuna de Sinopharm. NYTimes.com https://www.nytimes.com/es/interactive/2021/health/sinopharm-vacuna-covid.html
Corum, J. y Zimmer, K. (2021b, 21 de enero). Cómo funciona la vacuna de Pfizer-BioNTech. NYTimes.com https://www.nytimes.com/es/interactive/2021/health/pfizer-biontech-vacuna-covid.html
Corum, J. y Zimmer, K. (2021c, 5 de marzo). Cómo funciona la vacuna de Oxford-AstraZeneca. NYTimes.com https://www.nytimes.com/es/interactive/2021/health/oxford-astrazeneca-vacuna-covid.html
Cross, R. (2021, 8 de abril). UT Austin and Mont Sinai partner to create low-cost COVID-19 vaccine. Chemical and Engineering News. https://cen.acs.org/pharmaceuticals/vaccines/UT-Austin-Mount-Sinai-partner/99/i13
Elbaum, R. y Smith, A. (2020, 2 de diciembre). U.K. becomes first country to approve Pfizer-BioNTech COVID-19 vaccine. NBC News https://www.nbcnews.com/news/world/u-k-becomes-first-country-approve-pfizer-biontech-covid-19-n1249651
Food and Drug Administration (FDA). (2021, 23 de agosto). FDA Approves First Covid-19 Vaccine. https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine#:~:text=Today%2C%20the%20U.S.%20Food%20and,years%20of%20age%20and%20older
Food and Drug Administration (FDA). (2022, 29 de noviembre). COVID-19 Vaccines. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines
Naciones Unidas. (2022). World Population to reach 8 billion on 15 November 2022. https://www.un.org/en/desa/world-population-reach-8-billion-15-november-2022
Novavax. (2022). Our recombinant, protein based nano-particle vaccine technology. https://www.novavax.com/science-technology/recombinant-protein-based-nanoparticle-vaccine-technology
Organización Mundial de la Salud (OMS). (2020). WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access. https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access
Organización Mundial de la Salud (OMS). (2021). Los distintos tipos de vacunas que existen. https://www.who.int/es/news-room/feature-stories/detail/the-race-for-a-covid-19-vaccine-explained
Organización Mundial de la Salud (OMS). (2022). COVID-19 Dashboard. https://app.powerbi.com/view?r=eyJrIjoiMWNjNzZkNjctZTNiNy00YmMzLTkxZjQtNmJiZDM2MTYxNzEwIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9
Our World in Data. (2022). Vaccination Innovation from 1880 to 2020. https://ourworldindata.org/vaccination
Quezada, A. (2020). Los orígenes de la vacuna. Revista Médica Clínica Las Condes, 31(3-4). https://www.elsevier.es/es-revista-revista-medica-clinica-las-condes-202-pdf-S0716864020300535
Reuters. (2020, 30 de diciembre). China gives its first COVID-19 vaccine approval to Sinopharm. https://www.reuters.com/article/us-health-coronavirus-vaccine-china-idUSKBN29505P
Scancell. (s.f). Covidity. https://www.scancell.co.uk/covidity
Weintraub, A. (2020, 17 de abril). It could take 5 year for 2 leading COVID-19 vaccines to debut, AI analysis find. Fierce Pharma. https://www.fiercepharma.com/pharma/don-t-count-a-covid-19-vaccine-for-at-least-five-years-says-ai-based-forecast
Zimmer, C. (2021, 12 de julio). Researchers are hatching a low-cost coronavirus vaccine. NYTimes.com https://www.nytimes.com/2021/04/05/health/hexapro-mclellan-vaccine.html
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Universidad de Colima
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
China Global Review permite compartir, copiar y redistribuir el material en cualquier medio o formato; adaptar, remezclar, transformar y construir sobre el material, dando crédito a la obra de manera adecuada y proporcionando un enlace a la licencia, indicando si se han realizado cambios.
